Cell Biology Support
细胞生物学支持
基本信息
- 批准号:7753053
- 负责人:
- 金额:$ 21.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdenovirusesAdhesivesAnimalsBiologicalBloodBlood VesselsBudgetsCell Culture SystemCell Culture TechniquesCell LineCellsCellular biologyCultured CellsDecontaminationDermalEndothelial CellsEndotheliumEnsureEnzymesFibroblast Growth FactorFunctional disorderFundingGoalsGrowth FactorHumanHuman ResourcesIn VitroIndividualKnock-outLeukocytesMediationMedicalMethodologyModificationMusPriceProceduresProductionProteinsPublished CommentQuality ControlReagentRecombinantsResearchResearch PersonnelSerumSourceSterilityTechniquesTestingTissuesTrainingTransgenic MiceUmbilical veinVascular Endothelial CellWorkcostfetal bovine serumflasksgraduate studenthigh standardhuman tissuein vitro Modelneonatal humanneonatepenis foreskinprogramsresearch studyresponsetissue culturevector
项目摘要
INTRODUCTION TO REVISED CORE A: CELL BIOLOGY SUPPORT:
We appreciate the comments provided by reviewers and the fact that both reviewers found that Core A
personnel have the expertise to perform the proposed objectives. Thus, the objectives of the Core in this
revised application are unchanged. Reviewers raised a concern of overlap in funds available in each of the
projects for cell culture, and a concern as to whether the individual projects will have any overlapping function.
In response, we have revised the personnel effort and supply budget as suggested, with some modification as
explained in the budget justification. In regards to whether projects having overlapping function with Core A,
we believe they do not, neither in personnel effort or supple budget. Core A and the personnel in each Project
have some expertise in common, but the personnel in Core A alone provide the FTEs that actually isolate,
amplify and culture all human and all animal endothelial cells, all cell lines, and other cells used by
investigators in the Program, in the all correct plasticware formats for each specific experimental requirement
requested by the Project investigators. This provides a critical advantage to the Investigators in the Program
because Core personnel will use the highest standards of quality control on all cells, serum and growth factors
and all other necessary reagents used in in vitro experiments across the program.
修订核心A:细胞生物学支持简介:
我们感谢评审员提供的评论,以及两位评审员都发现核心A
工作人员具备实现拟议目标的专业知识。因此,核心在这方面的目标
修改后的应用程序不变。审查人员对每个项目的可用资金重叠表示关切,
此外,我们亦关注到,个别项目是否会有任何功能重叠。
作为回应,我们已按照建议修订了人员工作和供应预算,并作了一些修改,
在预算说明中解释。关于项目是否与核心A的职能重叠,
我们认为,无论是在人员努力方面,还是在灵活的预算方面,他们都没有做到这一点。核心A及各项目人员
有一些共同的专业知识,但核心A中的人员单独提供了实际隔离的FTE,
扩增和培养所有人和所有动物内皮细胞、所有细胞系和其他细胞,
研究人员在该计划中,在所有正确的塑料器皿格式为每个特定的实验要求
项目调查人员的要求。这为项目中的研究者提供了关键优势
因为核心人员将对所有细胞、血清和生长因子采用最高标准的质量控制,
以及整个项目中体外实验中使用的所有其他必要试剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANCIS W. LUSCINSKAS其他文献
FRANCIS W. LUSCINSKAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANCIS W. LUSCINSKAS', 18)}}的其他基金
CD47 Regulation of Leukocyte Integrins during Leukocyte Trafficking
白细胞贩运过程中 CD47 对白细胞整合素的调节
- 批准号:
9105867 - 财政年份:2016
- 资助金额:
$ 21.93万 - 项目类别:
2014 Annual Meeting of the American Society for Investigative Pathology
2014年美国病理研究学会年会
- 批准号:
8716277 - 财政年份:2014
- 资助金额:
$ 21.93万 - 项目类别:
2013 Annual Meeting of the American Society for Investigative Pathology
2013年美国病理研究学会年会
- 批准号:
8527049 - 财政年份:2013
- 资助金额:
$ 21.93万 - 项目类别:
The Role of CD47 in Mononuclear Leukocyte Recruitment
CD47 在单核白细胞募集中的作用
- 批准号:
7753041 - 财政年份:2009
- 资助金额:
$ 21.93万 - 项目类别:
ENDOTHELIAL LATERAL JUNCTIONS AND LEUKOCYTE TRAFFICKING
内皮横向连接和白细胞运输
- 批准号:
6602438 - 财政年份:2002
- 资助金额:
$ 21.93万 - 项目类别:
ENDOTHELIAL LATERAL JUNCTIONS AND LEUKOCYTE TRAFFICKING
内皮横向连接和白细胞运输
- 批准号:
6469264 - 财政年份:2001
- 资助金额:
$ 21.93万 - 项目类别:
相似海外基金
I-Corps: Translation Potential of Peptidic Ensembles as Novel Bio-adhesives
I-Corps:肽整体作为新型生物粘合剂的转化潜力
- 批准号:
2409620 - 财政年份:2024
- 资助金额:
$ 21.93万 - 项目类别:
Standard Grant
Architectural design of active adhesives
活性粘合剂的结构设计
- 批准号:
2403716 - 财政年份:2024
- 资助金额:
$ 21.93万 - 项目类别:
Standard Grant
Design of non-swellable adhesives for brain surgery using cyclodextrin inclusion polymer
使用环糊精包合物聚合物脑外科不可溶胀粘合剂的设计
- 批准号:
23H01718 - 财政年份:2023
- 资助金额:
$ 21.93万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Meta-material adhesives for improved performance and functionalisation of bondlines
超材料粘合剂可提高粘合层的性能和功能化
- 批准号:
EP/W019450/1 - 财政年份:2023
- 资助金额:
$ 21.93万 - 项目类别:
Fellowship
Light-propelled dental adhesives with enhanced bonding capability
具有增强粘合能力的光驱动牙科粘合剂
- 批准号:
10741660 - 财政年份:2023
- 资助金额:
$ 21.93万 - 项目类别:
DMREF: Accelerating the Design of Adhesives with Nanoscale Control of Thermomechanical Properties
DMREF:通过热机械性能的纳米级控制加速粘合剂的设计
- 批准号:
2323317 - 财政年份:2023
- 资助金额:
$ 21.93万 - 项目类别:
Continuing Grant
Mag-Cure: A novel method for magnetically induced bonding and de-bonding of thermoset adhesives in the Automotive Industry
Mag-Cure:汽车行业中热固性粘合剂磁感应粘合和脱粘的新方法
- 批准号:
10062336 - 财政年份:2023
- 资助金额:
$ 21.93万 - 项目类别:
Collaborative R&D
Biodegradable, Biocompatible Pressure Sensitive Adhesives
可生物降解、生物相容性压敏粘合剂
- 批准号:
10677869 - 财政年份:2022
- 资助金额:
$ 21.93万 - 项目类别:
Poly(glycerol carbonate) pressure sensitive adhesives for the in vivo closure of alveolar pleural fistulae
用于体内闭合肺泡胸膜瘘的聚(甘油碳酸酯)压敏粘合剂
- 批准号:
10746743 - 财政年份:2022
- 资助金额:
$ 21.93万 - 项目类别:
Enhanced bio-production of difficult to make peptide ingredients for specialty adhesives and personal care
增强用于特种粘合剂和个人护理品的难以制造的肽成分的生物生产
- 批准号:
10021363 - 财政年份:2022
- 资助金额:
$ 21.93万 - 项目类别:
Investment Accelerator














{{item.name}}会员




